THESE 4 STOCKS LOOK CHEAP 🚨 OCTOBER 29
4 extracted signals · 0 resolved · 4 still active
Overkill TradingIndependent analyst profile- Source published
- 29 Oct 2026, 18:50 UTC
- Recorded by Tahlil Plus
- 30 Oct 2026, 01:39 UTC
AI-generated source summary
The analysis focuses on four stocks identified as potentially undervalued due to significant price drops. The primary timeframe for analysis is the weekly chart (1W). For BIDU, the current price is around $77.03, with a target of $69.00 and a fail bound at $82.50, suggesting a bullish reversal from a oversold condition. MARA is trading at $7.14, with a target of $11.54 and a fail bound at $6.00, also indicating a potential bullish setup as it tests a long-term support level. BABA is currently at $99.15, with a target of $120.00 and a fail bound at $93.00, suggesting a potential bottoming pattern and reversal. MGM is trading at $28.21, with a target of $32.00 and a fail bound at $25.00, also showing signs of testing a significant support level with a bullish outlook. The presenter highlights that these stocks have experienced substantial declines, making them attractive for potential buying opportunities if oversold indicators confirm a reversal.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
4 eligible signals linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Live evaluation in progress
4 signals remain active.
Overkill Trading
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.